close

Login

Library
Shopping Cart
Remember Me
Forgot password/Login issues?
loading animation for AJAX calls
 
 
Direct (781) 489-7301,  Toll Free (866) 285-7215

Search

Search
BCC Advance Search

Human Reproductive Technologies: Products and Global Markets

  • Published: November 2013
  • |
  • Report Code: HLC017D

REPORT HIGHLIGHTS

The total market for reproductive technologies and products is estimated to achieve revenues of nearly $16.1 billion in 2013. In 2018, the forecasted revenues will likely reach $19.6 billion, demonstrating a compound annual growth rate (CAGR) of 4.1%.

This report provides:

  • An overview of the market for human reproductive technologies.
  • Analyses of market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018.
  • Examinations of market sizes in the categories of infertility, artificial reproductive technologies, fertility diagnostics, contraception, and sexual dysfunction, with a division of markets according to treatment type and indication.
  • Evaluations of pipeline products and technologies.
  • Patent analysis.

SAMPLE FIGURE
TOTAL REVENUES OF GLOBAL REPRODUCTIVE TECHNOLOGIES AND PRODUCTION AT ESTIMATED MANUFACTURERS’ SALES LEVELS, 2011-2018
($ BILLIONS)
TOTAL REVENUES OF GLOBAL REPRODUCTIVE TECHNOLOGIES AND PRODUCTION AT ESTIMATED MANUFACTURERS’ SALES LEVELS, 2011-2018
To Contact us, click here  help


Source: BCC Research

Download Report Overview

REPORT SCOPE

INTRODUCTION

STUDY GOALS AND OBJECTIVES

The objective of the study is to present a comprehensive, up-to-date look at the market for reproductive technologies and products. Markets are divided according to treatment type and indication. The products in some markets are mature, while products in other markets are just beginning to emerge. The report is directed to decision-makers in the various areas of reproductive drugs and technologies, and it provides insight into those arenas for current and future development.

REASONS FOR STUDY

This BCC Research study is presented to increase the awareness of the global reproductive market by identifying pharmaceutical preparations, devices, technologies and important advancements within the industry. The study analyzes the new therapeutics and technologies for reproductive health and it addresses issues and trends affecting the market. Manufacturers of pharmaceutical products, devices and technologies have stepped up discovery, as the engine driving growth in all markets is research and development.

SCOPE OF STUDY

The report is designed to be a comprehensive business tool to provide an in-depth look at the markets for reproductive drugs and technologies. The geographic scope of the report is global. The report reviews male and female reproductive health, presents standard pharmaceutical treatments and devices, and reviews technologies associated with reproductive health. The report also explores market size, identifies market participants and investigates pipeline products and technologies.

The global market for reproductive technologies and products is divided into categories by treatment type and indication as follows.

  • Infertility market—male and female factors, pharmaceuticals and future advancements.
    • IVF.
    • Assistive reproductive technologies. 
    • Fertility diagnostics.
  • Contraception—pharmaceuticals and devices.
  • Sexual dysfunction—pharmaceuticals and devices.

Each area is covered in detail, describing the disorder or treatment involved, identifying current products and treatments in the market in the base year 2013, measuring current market size and identifying current and potential market drivers, forecasting for 2018, assessing current and potential competitors and identifying current competitor market shares for the base year of 2013.

METHODOLOGY AND INFORMATION SOURCES

The information and analysis presented in this BCC Research report are based on extensive, first-hand interviews with primary executives, product managers and clinical specialists in the area of reproductive health. Random surveying provided information about the use of products and how products are obtained. Background information was obtained from various government and business sources, medical journals, and trade magazines and interviews with doctors. Key information from published literature was used to conduct interviews with industry participants to validate and obtain expert opinions on current and future trends in reproductive drugs and technologies in healthcare. Interviews were also used to confirm and/or adjust market size and competitor market share estimates, as well as to formulate market projections.

All market data pertain to the global market at the manufacturer’s level. Data are expressed in current U.S. dollars. The base year is 2013; historical data are provided for 2011 and 2012 and forecast data are provided for 2018. Historical, base year and forecast data are provided for each market segment and subsegment. Market share information is provided for each market subsegment for the 2013 base year.

All average annual growth rates are estimated based on the compilation of data, which includes estimated prevalence of conditions, population growth, products in research and development, historical trends, patent expirations and generic competition.

INTENDED AUDIENCE

This report was prepared as a study of the human reproductive technologies marketplace.  Information is presented on the human reproductive technologies industry in general, pharmaceuticals and devices, new technology within the market, new and novel drug applications and market-related issues; in many cases actual revenue is given for the period of 2011 and 2012, with projections of trends and compound annual growth rates (CAGRs) from 2013 through 2018. 

This study will be of significant interest to hospitals, pharmacies, pharmaceutical companies, biopharmaceutical researchers, pharmaceutical company marketing executives, contract research organizations (CROs), chemists,  physicians, nurses, physician assistants, pharmaceutical directors, product managers and representatives.  It also will be of interest to biologists and those interested in the field of reproductive technologies.  

ANALYST CREDENTIALS

Mary Anne Crandall is a Medical Analyst, specializing in the pharmaceuticals industry for 20 years, currently working on a Ph.D. She has completed several in-depth studies on various medical topics requiring both expertise and knowledge of the industry.

BCC RESEARCH ONLINE SERVICES

BCC Research offers an online information retrieval service. Its home page, located at www.bccresearch.com, enables readers to:

  • Examine the complete BCC Research catalog of market research reports and place direct orders.
  • Read announcements of recently published reports.
  • Register for its well-known conferences.
  • Request additional information on any BCC Research product.
  • Take advantage of special offers.

DISCLAIMER

The information developed in this report is intended to be as reliable as possible at the time of publication and is of a professional nature. This information does not constitute managerial, legal or accounting advice, nor should it be considered as a corporate policy guide, laboratory manual or an endorsement of any product, as much of the information is speculative in nature. BCC Research and the author assume no responsibility for any loss or damage that might result from reliance on the reported information or from its use.

Download Report Overview

REPORT TOC

download table of contents
Pricing on the website is provided for single users and 2-5 users licenses only. All reports will be provided in a PDF format for download. To purchase multi-user licenses, please contact us at (+1)781-489-7301 or send an email to information@bccresearch.com
  Title/Chapter Name Pages Price
Human Reproductive Technologies: Products and Global Markets 175 $6650
Chapter- 1: INTRODUCTION - Complimentary 3 $0
  Show Details
Chapter- 2: SUMMARY 2 $250
  Show Details
Chapter- 3: INDUSTRY OVERVIEW 40 $2280
  Show Details
Chapter- 4: INFERTILITY MARKET 12 $684
  Show Details
Chapter- 5: METHODS OF TREATMENT 11 $627
  Show Details
Chapter- 6: ASSISTIVE REPRODUCTIVE TECHNOLOGIES 14 $798
  Show Details
Chapter- 7: FERTILITY DIAGNOSTICS 7 $399
  Show Details
Chapter- 8: CONTRACEPTION MARKET 27 $1539
  Show Details
Chapter- 9: SEXUAL DYSFUNCTION MARKET 14 $798
  Show Details
Chapter- 10: PATENTS 2 $114
  Show Details
Chapter- 11: LEADING MARKET MANUFACTURERS 2 $114
  Show Details
Chapter- 12: TOTAL MARKET 9 $513
  Show Details
Chapter- 13: PARTICIPATING COMPANIES 9 $513
  Show Details
Chapter- 14: APPENDIX A 19 $1083
  Show Details
Chapter- 15: APPENDIX B: LIST OF COMPANIES 4 $228
  Show Details
 
  List of Tables
  List of Figures
Recommended combos for Forecast Model
+

BCC Research Report

Price: $6650

=

Total Price: $12150

Combo Price: $9500

Discount will be applied automatically after you will add the forecast model and any report to your cart.

 
Select License type:
buy now
downlaod report overview
Want to find out more
about this report?
request more info
Get Notified
on all the latest research reports
Subscribe

Choose your License

loading animation for AJAX calls